Evidence map›Paper›PMID 41599065›Full record

ReviewPathogens (Basel, Switzerland)2026

Treating Extensively Drug-Resistant

Anastasia Geladari, Dimitrios Kouroupis, Kyriaki Vafeidou, Vasileios Liakos, Maria Magoudi, Anastasia-Izampella Papathanasiou, Elias Iosifidis, Emmanuel Roilides, Charalampos Antachopoulos, Athina Pyrpasopoulou

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anastasia GeladariInfectious Diseases Unit, Hippokration General Hospital, 54642 Thessaloniki, Greece.
Dimitrios Kouroupis2nd Propedeutic Department of Internal Medicine, Aristotle University, Hippokration General Hospital, 54642 Thessaloniki, Greece.ORCID 0009-0005-7732-709X
Kyriaki Vafeidou2nd Propedeutic Department of Internal Medicine, Aristotle University, Hippokration General Hospital, 54642 Thessaloniki, Greece.
Vasileios LiakosInfectious Diseases Unit, Hippokration General Hospital, 54642 Thessaloniki, Greece.ORCID 0009-0003-1221-6618
Maria Magoudi2nd Propedeutic Department of Internal Medicine, Aristotle University, Hippokration General Hospital, 54642 Thessaloniki, Greece.
Anastasia-Izampella PapathanasiouInfectious Diseases Unit, Hippokration General Hospital, 54642 Thessaloniki, Greece.
Elias IosifidisInfectious Diseases Unit, Hippokration General Hospital, 54642 Thessaloniki, Greece.ORCID 0000-0001-9881-451X
Emmanuel RoilidesInfectious Diseases Unit, Hippokration General Hospital, 54642 Thessaloniki, Greece.ORCID 0000-0002-0202-364X
Charalampos AntachopoulosInfectious Diseases Unit, Hippokration General Hospital, 54642 Thessaloniki, Greece.
Athina PyrpasopoulouInfectious Diseases Unit, Hippokration General Hospital, 54642 Thessaloniki, Greece.ORCID 0000-0002-6906-2504

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialCarbapenemsCross InfectionHumansAnti-Bacterial AgentsCarbapenemsAcinetobacter baumaniicarbapenem-resistantsynergytreatment

Identifiers

PMID41599065
PMCPMC12844807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.